Back
Heron Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
HRTX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
20
HRTX
Heron Therapeutics
Last Price:
2.06
Seasonality Move:
-7.28%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Heron Therapeutics Price Quote
$2.06
+0.06 (+2.74%)
(Updated: September 20, 2024 at 4:20 PM ET)
Heron Therapeutics Key Stats
Sell
20
Heron Therapeutics (HRTX)
is a Sell
Day range:
$1.95 - $2.11
52-week range:
$0.50 - $3.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.20
P/B ratio:
0%
Volume:
2.5M
Avg. volume:
2.1M
1-year change:
75.88%
Market cap:
$304.1M
Revenue:
$127M
EPS:
$-0.3
How Much Does Heron Therapeutics Make?
-
How Much Are Heron Therapeutics's Sales Annually?
HRTX Revenues are $127M -
How Much Profit Does Heron Therapeutics's Make A Year?
HRTX net income is -$110.6M
Is Heron Therapeutics Growing As A Company?
-
What Is Heron Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.13% -
What Is Heron Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Heron Therapeutics Stock Price Performance
-
Did Heron Therapeutics Stock Go Up Last Month?
Heron Therapeutics share price went up by 1.26% last month -
Did HRTX's Share Price Rise Over The Last Year?
HRTX share price rose by 75.88% over the past 1 year
What Is Heron Therapeutics 52-Week High & Low?
-
What Is Heron Therapeutics’s 52-Week High Share Price?
Heron Therapeutics has traded as high as $3.93 over the past 52 weeks -
What Is Heron Therapeutics’s 52-Week Low Share Price?
Heron Therapeutics has traded as low as $0.50 over the past 52 weeks
Heron Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Heron Therapeutics?
-
How Much Debt Does Heron Therapeutics Have?
Total long term debt quarterly is $174.2M -
How Much Cash Does Heron Therapeutics Have?
Cash and short term investments quarterly total is $67.3M -
What Is Heron Therapeutics’s Book Value Per Share?
Book value per share is -0.25
Is Heron Therapeutics Cash Flow Positive?
-
What Is HRTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$20.8M -
What Is Heron Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $54.5M -
What Is Heron Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$28.7M
Heron Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
HRTX return on invested capital is -35.81% -
What Is Heron Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -22.1% -
What Is HRTX Return On Equity?
ROE is a measure of profitability and is 0%
Heron Therapeutics Earnings Date & Stock Price
-
What Is Heron Therapeutics's Stock Price Today?
A single share of HRTX can be purchased today for 2.01 -
What Is Heron Therapeutics’s Stock Symbol?
Heron Therapeutics trades on the nasdaq under the ticker symbol: HRTX -
When Is Heron Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Heron Therapeutics is scheduled on November 14, 2024 -
When Is HRTX's next ex-dividend date?
Heron Therapeutics's next ex-dividend date is May 12, 2020 -
How To Buy Heron Therapeutics Stock?
You can buy Heron Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Heron Therapeutics Competitors
-
Who Are Heron Therapeutics's Competitors?
Below is a list of companies who compete with Heron Therapeutics or are related in some way:
Heron Therapeutics Dividend Yield
-
What Is HRTX Dividend Yield?
Heron Therapeutics’s dividend yield currently is 0% -
What Is Heron Therapeutics’s Payout Ratio?
Heron Therapeutics’s payout ratio is 0% -
When Did Heron Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Heron Therapeutics’s Dividend Per Share?
Heron Therapeutics pays a dividend of $0.00 per share
Heron Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -28.56% |
Revenue: | 13.42% | 0.38% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 6.75 |
Upside from Last Price: | 236.66% |